The diabetes stem cell field has recently leveraged this technology to correct the WFS1 pathogenic variant using CRISPR/Cas9 gene-edited SC-islets from a patient with Wolfram syndrome to reverse preexisting diabetes in a mouse (49). Here, WFS1 is linked to Wolfram syndrome.